Thr285

Javascript is not enabled on this browser. This site will not work properly without Javascript.

Home > Phosphorylation Site Page: > Thr285 - WWTR1 (human)

Site Information
AVNPPTMtPDMRsIT SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 41594200

In vivo Characterization
Methods used to characterize site in vivo:	mutation of modification site ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:	HeLa (cervical) ( 1 )

Upstream Regulation
Putative in vivo kinases:	CDK1 (human) ( 1 )
Treatments:	taxol ( 1 )

Downstream Regulation
Effects of modification on WWTR1:	protein degradation ( 1 )

References
1	Zhao Y, Yang X (2015) Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling. Oncotarget 6, 21906-17 26183396 Curated Info

Developed with grants from

and literature mining with Linguamatics

PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.